|
| Press Releases |
|
 |
|
| Monday, October 5, 2020 |
|
|
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. |
| Document Security Systems, Inc. today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") has formed a new wholly owned subsidiary, Innate Immune, Inc. ("Innate Immune"), to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. more info >> |
|
| Friday, September 18, 2020 |
|
|
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance |
| Document Security Systems, Inc. (NYSE American: DSS) today announced its wholly owned subsidiary Impact BioMedical, Inc., through its subsidiary Global BioLife, Inc., completed efficacy testing of its proprietary 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. more info >> |
|
| Friday, July 31, 2020 |
|
|
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. more info >> |
|
| Wednesday, June 24, 2020 |
|
|
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. more info >> |
|
| Wednesday, June 17, 2020 |
|
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and Discovery Group Sciences ("GRDG"), conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc. ("Vilotos"), was published in the peer-reviewed scientific journal Molecules on June 11, 2020. more info >> |
|
| Monday, June 1, 2020 |
|
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts |
| SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc., would like to update its stakeholders on its suite of antiviral and medical technologies. more info >> |
|
| Friday, April 24, 2020 |
|
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts |
| SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, co-owned with its partners, is valued at USD 592 Million (SGD 841 Million). Impact Biomedical's effective ownership of 64.53% in the suite of technologies equates to a value of USD 382 Million (SGD 542 Million). more info >> |
|
| Wednesday, March 18, 2020 |
|
|
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak |
| Singapore Exchange-listed Singapore eDevelopment Limited has announced that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. ("GRDG"), recently conducted molecular docking studies, utilizing advanced computational models, which indicate Linebacker and Equivir successfully inhibit infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. more info >> |
|
| Friday, November 15, 2019 |
|
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
| Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
| Tuesday, October 29, 2019 |
|
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
| SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Viet Capital Bank to issue JCB Corporate Credit Card
Apr 21, 2021 11:00 HKT/SGT
|
.jpg)
|
|
コインスター、3月のマシン設置実績発表
Apr 21, 2021 10:00 HKT/SGT
|
|
|
コインスター、3月のマシン設置実績発表
Apr 21, 2021 10:00 HKT/SGT
|
|
|
Anacle's Tesseract Selected by Energy Market Authority to Develop and Testbed NB-IoT-enabled Advanced Electricity Meters
Apr 21, 2021 9:37 HKT/SGT
|
|
|
Anacle's Tesseract Selected by the EMA to Develop and Testbed NB-IoT-enabled Advanced Electricity Meters
Apr 21, 2021 08:00 HKT/SGT
|
|
|
Edvantage Group (0382.HK) Interim Results Exceed Expectations, Adjusted Net Profit Up 32.5% to RMB199.9 Million
Apr 21, 2021 00:35 HKT/SGT
|
|
|
Redsun Services Acquires 80% Equity Interest in Each of Gaoli Property and Jiangsu Gaoli Meijia for RMB73.54 Million
Apr 21, 2021 00:08 HKT/SGT
|
|
|
弘陽服務以人民幣7,354萬元收購高力物業及江蘇高力美家80%權益
Apr 20, 2021 22:09 HKT/SGT
|
|
|
中汇集团（0382. HK）2021财年中期业绩超预期
Apr 20, 2021 21:20 HKT/SGT
|
|
|
中滙集團（0382. HK）2021財年中期業績超預期
Apr 20, 2021 21:19 HKT/SGT
|
|
|
Torum Closes Million Dollars Private Round to Create The First Social Media Platform with NFT & DeFi Innovations
Apr 20, 2021 20:00 HKT/SGT
|
|
|
Torum Closes Million Dollars Private Round to Create The First Social Media Platform with NFT & DeFi Innovations
Apr 20, 2021 21:00 HKT/SGT
|
|
|
문스테이크, 창업 1주년 기념! 1년만에 세계 10대 스테이킹 업체로 급성장
Apr 20, 2021 20:00 HKT/SGT
|
|
|
Moonstake1周年を迎える 1年で世界トップ10のステーキングプロバイダーに急成長
Apr 20, 2021 19:00 HKT/SGT
|
|
|
Moonstake Celebrates Our First Anniversary - World's Top 10 Staking Providers in One Year
Apr 20, 2021 20:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
